The following is a summary of “Efficacy and safety of PD-1/PD-L1 inhibitor monotherapy or combination therapy versus platinum-based chemotherapy as a first-line treatment of advanced urothelial cancer ...

Promising therapies for platinum-resistant ovarian cancer produced mixed results in separate trials. The AKT inhibitor ...

A new study, published in the peer-reviewed journal AI in Precision Oncology, examines the ability of large language models ...

Journal of the American Medical Association study provides further evidence that Multikine can treat unmet need in ~70% of ...

Tislelizumab plus chemotherapy received FDA approval as a frontline therapy for individuals with unresectable or metastatic ...

Patients with PD-L1-positive tumors lived more than seven months longer on Tevimbra added to chemotherapy compared to just chemo.

A new study published in AI in Precision Oncology examines the ability of large language models (LLMs) to rapidly extract ...